Hosted on MSN1mon
Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations
"Global pharma major ... facility in Somerset, New Jersey. The inspection was carried out from January 28 to February 1, 2025, and concluded with zero 483 observations," the company said in ...
Pharmabiz29d
Lupin receives EIR from US FDA for its Somerset manufacturing facility
“We are very pleased to have received the EIR for our Somerset facility ... and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a ...